EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

2′-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Modulating the Intestinal Microbiome

Yeon-Ji Kim, Han-Hae Kim, Chul-Soo Shin, Jong-Won Yoon, Seon-Min Jeon, Young-Ha Song iD, Kwang-Youn Kim iD, Kyungho Kim

Nutrients · 12.04.2023 · 15 (8) · 1845

DOI: 10.3390/nu15081845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 12.04.2023. Verfasst von Yeon-Ji Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Korean Medicine (KM)-Application Center, Korea Institute of Oriental Medicine (KIOM), Daegu 41062, Republic of Korea. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Colitis, Ulcerative. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Advanced Protein Technologies Corp..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis is an inflammatory bowel disease (IBD) with relapsing and remitting patterns, and it is caused by varied factors, such as the intestinal inflammation extent and duration. We examined the preventative effects of human milk oligosaccharides (HMOs) on epithelial barrier integrity and intestinal inflammation in an interleukin (IL)-6-induced cell model and dextran sodium sulfate (DSS)-induced acute mouse colitis model. HMOs including 2′-fucosyllactose (FL) and 3-FL and positive controls including fructooligosaccharide (FOS) and 5-acetylsalicylic acid (5-ASA) were orally administrated once per day to C57BL/6J mice with colitis induced by 5% DSS in the administered drinking water. 2′-FL and 3-FL did not affect the cell viability in Caco-2 cells. Meanwhile, these agents reversed IL-6-reduced intestinal barrier function in Caco-2 cells. Furthermore, 2′-FL and 3-FL reversed the body weight loss and the remarkably short colon lengths in DSS-induced acute colitis mice. Moreover, 2′-FL and 3-FL obviously protected the decreasing expression of zonula occluden-1 and occludin in colon tissue relative to the findings in the DSS-treated control group. 2′-FL and 3-FL significantly reduced IL-6 and tumor necrosis factor-α levels in serum relative to the control findings. The summary of these results shows that HMOs prevent colitis mainly by enhancing intestinal barrier function and advancing anti-inflammatory responses. Therefore, HMOs might suppress inflammatory responses and represent candidate treatments for IBD that protect intestinal integrity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColitisColitis, UlcerativeHumansMiceAnimalsInterleukin-6DextransCaco-2 CellsMice, Inbred C57BLColonOligosaccharidesInflammationDextran SulfateDisease Models, AnimalIntestinal MucosaTrisaccharidesSulfates

Stichwörter der Autor:innen

2′-fucosyllactose3-fucosyllactoseinflammationtight junctionulcerative colitis

Substanzen

Interleukin-6DextransOligosaccharidesDextran Sulfate2'-fucosyllactoseTrisaccharidessodium sulfateSulfates

Autor:innen und Institutionen

  • Korean Medicine (KM)-Application Center, Korea Institute of Oriental Medicine (KIOM), Daegu 41062, Republic of Korea.
  • Advanced Protein Technologies Corp., Suwon 16229, Republic of Korea.

ORCID-Profile: Young-Ha Song, Kwang-Youn Kim

Förderung

  • Advanced Protein Technologies Corp.

Zitieren

APA

Kim, Y. J., Kim, H. H., Shin, C. S., Yoon, J. W., Jeon, S. M., Song, Y. H., Kim, K. Y., & Kim, K. (2023). 2′-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Modulating the Intestinal Microbiome. Nutrients, 15(8), 1845. https://doi.org/10.3390/nu15081845

Vancouver

Kim YJ, Kim HH, Shin CS, Yoon JW, Jeon SM, Song YH, et al. 2′-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Modulating the Intestinal Microbiome. Nutrients. 2023;15(8):1845. doi:10.3390/nu15081845

BibTeX
@article{Kim2023,
  author = {Kim, Yeon-Ji and Kim, Han-Hae and Shin, Chul-Soo and Yoon, Jong-Won and Jeon, Seon-Min and Song, Young-Ha and Kim, Kwang-Youn and Kim, Kyungho},
  title = {2′-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Modulating the Intestinal Microbiome},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {1845},
  doi = {10.3390/nu15081845}
}
Kostenlos starten →